isoniazid has been researched along with Exanthem in 24 studies
Hydra: A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.
hydrazide : Compounds derived from oxoacids RkE(=O)l(OH)m (l =/= 0) by replacing -OH by -NRNR2 (R groups are commonly H). (IUPAC).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pellagra is caused by niacin (vitamin B3) deficiency and patients with pellagra present with a characteristic rash." | 8.12 | Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control study. ( Auld, AF; Buono, N; Chilikutali, L; Chisuwo, L; Chiwaula, MJ; da Silva, R; Girma, B; Gunde, LJ; Gutreuter, S; Jahn, A; Kalua, T; Kaunda, E; Kim, EJ; Kumwenda, T; Maida, A; Maphosa, T; Marshall, RE; Mbewe, K; Mekonnen, TF; Melgar, M; Mhango, V; Moffitt, A; Mponda, K; Mtoto, F; Muula, AS; Mwamale, S; Mwenyeheri, G; Nabity, SA; Nagoli, E; Ngongonda, D; Nyirenda, R; Odo, M; Oeltmann, JE; Sharma, AJ; Sunguti, J; Surie, D; Williams, AM; Woelk, G; Zimba, SB, 2022) |
| "The use of bacillus Calmette-Guérin in the treatment of transitional cell cancer of the bladder has caused concern because of its associated adverse effects." | 6.69 | The effect of isoniazid on BCG-induced toxicity in patients with superficial bladder cancer. ( Al Khalifa, M; Callaghan, P; Colleen, S; Duchek, M; Elfving, P; Eriksson, R; Hagberg, G; Hellsten, S; Månsson, W; Nelson, CE; Nyberg, G; Olsson, R; Rademark, C, 2000) |
| "Pellagra is caused by niacin (vitamin B3) deficiency and patients with pellagra present with a characteristic rash." | 4.12 | Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control study. ( Auld, AF; Buono, N; Chilikutali, L; Chisuwo, L; Chiwaula, MJ; da Silva, R; Girma, B; Gunde, LJ; Gutreuter, S; Jahn, A; Kalua, T; Kaunda, E; Kim, EJ; Kumwenda, T; Maida, A; Maphosa, T; Marshall, RE; Mbewe, K; Mekonnen, TF; Melgar, M; Mhango, V; Moffitt, A; Mponda, K; Mtoto, F; Muula, AS; Mwamale, S; Mwenyeheri, G; Nabity, SA; Nagoli, E; Ngongonda, D; Nyirenda, R; Odo, M; Oeltmann, JE; Sharma, AJ; Sunguti, J; Surie, D; Williams, AM; Woelk, G; Zimba, SB, 2022) |
| "This study identifies the presence of isoniazid/rifampicin-specific T cells in patients with ATD-induced maculopapular exanthema and DRESS." | 3.85 | Drug-specific CD4 ( Ban, GY; Hur, GY; Jee, YK; Kim, SH; Naisbitt, DJ; Park, HS; Ye, YM, 2017) |
| " She had pulmonary tuberculosis and developed a fever, systemic exudative erythema, exanthema, and epidermolysis covering 30% of her body surface area while being treated with four agents, including isoniazid (INH) and rifampicin (RFP)." | 3.78 | [A case of Stevens-Johnson syndrome (SJS) progressive toxic epidermal necrolysis (TEN) onset during hyposensitization therapy for pulmonary tuberculosis complicated with dermatomyositis]. ( Mimori, A; Takahashi, Y; Ueda, Y; Yamashita, H, 2012) |
| "In a series of 1,212 tuberculosis patients treated on a regime of streptomycin/isoniazid/thiacetazone (S/INH/thiacetazone) over a period of 10 years in Nigeria there were 171 cases considered to have toxic reactions to thiacetazone (14%)." | 3.66 | Thiacetazone toxicity in the treatment of tuberculosis patients in Nigeria. ( Pearson, CA, 1978) |
| "The use of bacillus Calmette-Guérin in the treatment of transitional cell cancer of the bladder has caused concern because of its associated adverse effects." | 2.69 | The effect of isoniazid on BCG-induced toxicity in patients with superficial bladder cancer. ( Al Khalifa, M; Callaghan, P; Colleen, S; Duchek, M; Elfving, P; Eriksson, R; Hagberg, G; Hellsten, S; Månsson, W; Nelson, CE; Nyberg, G; Olsson, R; Rademark, C, 2000) |
| "Pyrazinamide, which was readministered last (at the full dose in one case and at progressive doses in the two others), induced a recurrence in two of them." | 1.30 | [Eruption after the 1st dose of standard antitubercular chemotherapy. Thoughts on pyrazinamide]. ( Autret, E; Carré, P; Jonville-Bera, AP; Lemarié, E; Radal, M; Van-Egroo, C, 1998) |
| "Pyrazinamide, which was re-administered last, induced a recurrence." | 1.30 | -Skin eruption after the first dose of antitubercular quadri-therapy: consideration of pyrazinamide-. ( Autret, E; Jonville-Béra, AP; Martel, C; Mazaud, S; Olivier, C; Radal, M, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (33.33) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 5 (20.83) | 24.3611 |
| 2020's | 4 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Calpena Martínez, S | 1 |
| Carrillo Acosta, I | 1 |
| Álvarez Álvarez, B | 1 |
| Górgolas Hernández-Mora, M | 1 |
| Nabity, SA | 1 |
| Mponda, K | 1 |
| Gutreuter, S | 1 |
| Surie, D | 1 |
| Zimba, SB | 1 |
| Chisuwo, L | 1 |
| Moffitt, A | 1 |
| Williams, AM | 1 |
| Sharma, AJ | 1 |
| Marshall, RE | 1 |
| Chiwaula, MJ | 1 |
| da Silva, R | 1 |
| Kumwenda, T | 1 |
| Chilikutali, L | 1 |
| Mwamale, S | 1 |
| Nagoli, E | 1 |
| Mwenyeheri, G | 1 |
| Ngongonda, D | 1 |
| Kaunda, E | 1 |
| Mtoto, F | 1 |
| Mhango, V | 1 |
| Mbewe, K | 1 |
| Melgar, M | 1 |
| Odo, M | 1 |
| Jahn, A | 1 |
| Buono, N | 1 |
| Maida, A | 1 |
| Girma, B | 1 |
| Kalua, T | 1 |
| Nyirenda, R | 1 |
| Sunguti, J | 1 |
| Woelk, G | 1 |
| Gunde, LJ | 1 |
| Mekonnen, TF | 1 |
| Maphosa, T | 1 |
| Kim, EJ | 1 |
| Auld, AF | 1 |
| Muula, AS | 1 |
| Oeltmann, JE | 1 |
| Kedar, AK | 1 |
| Wagh, PB | 1 |
| Gupta, N | 1 |
| Mittal, A | 1 |
| Nischal, N | 1 |
| Chiang, LY | 1 |
| Baumann, B | 1 |
| Romanowski, K | 1 |
| Kumar, D | 1 |
| Campbell, JR | 1 |
| Djurdjev, O | 1 |
| Morshed, M | 1 |
| Sekirov, I | 1 |
| Cook, VJ | 1 |
| Levin, A | 1 |
| Johnston, JC | 1 |
| Logsdon, S | 1 |
| Ramirez-Avila, L | 1 |
| Castells, M | 1 |
| Dioun, A | 1 |
| Zhang, SN | 1 |
| He, QX | 1 |
| Yang, NB | 1 |
| Ni, SL | 1 |
| Lu, MQ | 1 |
| Ye, YM | 1 |
| Hur, GY | 1 |
| Kim, SH | 2 |
| Ban, GY | 1 |
| Jee, YK | 1 |
| Naisbitt, DJ | 1 |
| Park, HS | 1 |
| Vedove, CD | 1 |
| Del Giglio, M | 1 |
| Schena, D | 1 |
| Girolomoni, G | 1 |
| Yamashita, H | 1 |
| Ueda, Y | 1 |
| Takahashi, Y | 1 |
| Mimori, A | 1 |
| CRISSEY, JT | 1 |
| OSBORNE, ED | 1 |
| JORDON, JW | 1 |
| BOWER, G | 1 |
| Story, RE | 1 |
| Ditto, AM | 1 |
| Schuhmachers, R | 1 |
| DeSwarte, RD | 1 |
| Schaberg, T | 1 |
| Rebhan, K | 1 |
| Lode, H | 1 |
| Radal, M | 2 |
| Jonville-Bera, AP | 2 |
| Van-Egroo, C | 1 |
| Carré, P | 1 |
| Lemarié, E | 1 |
| Autret, E | 2 |
| Olivier, C | 1 |
| Mazaud, S | 1 |
| Martel, C | 1 |
| Al Khalifa, M | 1 |
| Elfving, P | 1 |
| Månsson, W | 1 |
| Colleen, S | 1 |
| Hellsten, S | 1 |
| Duchek, M | 1 |
| Nyberg, G | 1 |
| Callaghan, P | 1 |
| Rademark, C | 1 |
| Eriksson, R | 1 |
| Olsson, R | 1 |
| Hagberg, G | 1 |
| Nelson, CE | 1 |
| Gilroy, SA | 1 |
| Rogers, MA | 1 |
| Blair, DC | 1 |
| Pearson, CA | 1 |
| Bandmann, HJ | 1 |
| Krebs, A | 1 |
| Stoll, E | 1 |
| Williner, B | 1 |
| Rubinstein, A | 1 |
| Zala, L | 1 |
| Fellner, MJ | 1 |
1 review available for isoniazid and Exanthem
| Article | Year |
|---|---|
Drug-induced lupus erythematosus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Antibodies; Antifungal Ag | 2009 |
1 trial available for isoniazid and Exanthem
| Article | Year |
|---|---|
The effect of isoniazid on BCG-induced toxicity in patients with superficial bladder cancer.
Topics: Administration, Intravesical; Aged; Antitubercular Agents; BCG Vaccine; Carcinoma in Situ; Carcinoma | 2000 |
22 other studies available for isoniazid and Exanthem
| Article | Year |
|---|---|
A case report. Rediscovering tuberculostatics drugs: skin rash and pyrazinamide.
Topics: Antitubercular Agents; Exanthema; Humans; Isoniazid; Pyrazinamide | 2022 |
Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control study.
Topics: Antitubercular Agents; Case-Control Studies; Exanthema; Female; HIV Infections; Humans; Isoniazid; M | 2022 |
Isoniazid-induced lichenoid eruption reaction.
Topics: Exanthema; Humans; Isoniazid; Lichenoid Eruptions | 2023 |
Drug rash vs. immune reconstitution inflammatory syndrome (IRIS)-a diagnostic dilemma.
Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Diagnosis, Differential; Exanthe | 2019 |
Latent Tuberculosis Therapy Outcomes in Dialysis Patients: A Retrospective Cohort.
Topics: Aged; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cohort Studies; Exanthema; Fema | 2021 |
Successful rifampin desensitization in a pediatric patient with latent tuberculosis.
Topics: Child; Clinical Protocols; Contraindications; Desensitization, Immunologic; Diphenhydramine; Drug Do | 2014 |
Isoniazid-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Presenting as Acute Eosinophilic Myocarditis.
Topics: Adult; Antitubercular Agents; Drug Eruptions; Exanthema; Humans; Hypereosinophilic Syndrome; Isoniaz | 2015 |
Drug-specific CD4
Topics: Adult; Antitubercular Agents; CD4-Positive T-Lymphocytes; Drug Hypersensitivity Syndrome; Exanthema; | 2017 |
[A case of Stevens-Johnson syndrome (SJS) progressive toxic epidermal necrolysis (TEN) onset during hyposensitization therapy for pulmonary tuberculosis complicated with dermatomyositis].
Topics: Dermatomyositis; Desensitization, Immunologic; Exanthema; Female; Humans; Immunoglobulins, Intraveno | 2012 |
Eczematous complications in treatment of tuberculosis; eruptions resulting from combined aminosalicylic acid, dihydrostreptomycin, and isoniazid therapy.
Topics: Aminosalicylic Acid; Dihydrostreptomycin Sulfate; Eczema; Exanthema; Humans; Isoniazid; Tuberculosis | 1957 |
SKIN RASH, HEPATITIS, AND HEMOLYTIC ANEMIA CAUSED BY PARA-AMINOSALICYLIC ACID.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anemia; Anemia, Hemolytic; Chemical and Drug Induced Live | 1964 |
A 32-year-old man with tuberculosis, fever, and rash.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Drug Hypersensitivity; Ethambutol; Exanthema; | 2004 |
[2 cases of a lichenoid tuberculid (Lichen scrophulosorum)].
Topics: Aged; Exanthema; Female; Humans; Isoniazid; Male; Middle Aged; Tuberculosis, Cutaneous; Tuberculosis | 1967 |
Drug allergy--problems and strategies.
Topics: Anaphylaxis; Anemia, Hemolytic; Antigen-Antibody Complex; Desensitization, Immunologic; Dose-Respons | 1984 |
Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antitubercular Agents; Arthralgia; Child; C | 1996 |
[Eruption after the 1st dose of standard antitubercular chemotherapy. Thoughts on pyrazinamide].
Topics: Aged; Antitubercular Agents; Child; Drug Combinations; Drug Eruptions; Ethambutol; Exanthema; Female | 1998 |
-Skin eruption after the first dose of antitubercular quadri-therapy: consideration of pyrazinamide-.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Combinations; Drug Eruptions; Ethamb | 1998 |
Treatment of latent tuberculosis infection in patients aged > or =35 years.
Topics: Adolescent; Adult; Alanine Transaminase; Arthralgia; Cohort Studies; Exanthema; Fatigue; Follow-Up S | 2000 |
Thiacetazone toxicity in the treatment of tuberculosis patients in Nigeria.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Dizziness; Drug Combinations; Drug Eruptions; Drug | 1978 |
[Histology of drug exanthema (histopathology of hematogenic contact eczema)].
Topics: Adult; Dermatitis, Contact; Drug Eruptions; Eczema; Exanthema; Female; Humans; Inflammation; Isoniaz | 1970 |
[Cutaneous miliary sarcoidosis in a child].
Topics: Diagnosis, Differential; Exanthema; Humans; Infant; Isoniazid; Male; Prednisone; Sarcoidosis; Skin T | 1972 |
[Adverse effects of isoniazid].
Topics: Desensitization, Immunologic; Diagnosis, Differential; Drug Hypersensitivity; Drug Tolerance; Exanth | 1970 |